GlassScriptPhysician profile
Robert M Baldwin
NPI 1558624841
$4,524.71
in general payments reported to CMS, 2019-2025
38 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,605 · 2020: $512 · 2023: $308 · 2024: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.97 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $526.23 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $493.66 | 2019-2024 | Ultomiris |
| Supernus Pharmaceuticals, INC. | $395.75 | 2019-2020 | |
| Ucb, INC. | $373.25 | 2019-2020 | |
| Genzyme Corporation | $322.36 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $269.89 | 2019 | |
| Biogen, INC. | $221.50 | 2019-2020 | |
| Allergan, INC. | $191.26 | 2019-2020 | |
| Genentech USA, INC. | $183.07 | 2019-2020 | |
| Amgen INC. | $156.58 | 2019 | |
| Sunovion Pharmaceuticals INC. | $137.48 | 2019-2020 | |
| Lilly USA, LLC | $123.57 | 2019-2023 | Emgality |
| Acadia Pharmaceuticals INC | $119.78 | 2019 | |
| Csl Behring | $98.91 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $81.56 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $79.04 | 2019-2020 | |
| Grifols USA, LLC | $70.51 | 2019 | |
| Eisai INC. | $68.37 | 2019 | |
| Acorda Therapeutics, INC | $60.06 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $58.12 | 2019 | |
| Jazz Pharmaceuticals INC. | $56.41 | 2019-2020 | |
| Boston Scientific Corporation | $49.87 | 2019-2020 | |
| Greenwich Biosciences, INC. | $47.53 | 2019 | |
| Adamas Pharmaceuticals, INC. | $46.16 | 2019 | |
| Medtronic USA, INC. | $39.97 | 2019 | |
| Abbott Laboratories | $31.46 | 2019-2020 | |
| Harmony Biosciences LLC | $28.58 | 2020 | |
| Livanova USA, INC. | $28.50 | 2019 | |
| Alnylam Pharmaceuticals INC. | $28.17 | 2019-2020 | |
| Catalyst Pharmaceuticals, INC. | $19.36 | 2019 | |
| Ge Healthcare | $17.68 | 2019 | |
| Promius Pharma LLC | $16.07 | 2019 | |
| Aquestive Therapeutics, INC. | $15.90 | 2019 | |
| Abbvie INC. | $15.08 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.93 | 2020 | |
| Tanabe Pharma America, INC. | $12.98 | 2020 | |
| Neurocrine Biosciences, INC. | $12.78 | 2019 | |
| Collegium Pharmaceutical, INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Baldwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.